Aposan pump brings normalcy in 69 year old Parkinson’s disease patients life

The APOSAN pump is an infusion pump specially designed for continuous subcutaneous infusion of Apomorphine in managing the symptoms of Parkinson’s disease

APOSAN, Parkinson, Consultant Neurologist, Neurology, Apomorphine HCL, Pump, Venkateswarlu, Rusan Pharma, Drug Controller General of India, Naveen Thota, General of India

69-year-old Dr Vendanapu Venkateswarlu, a resident of Vijayawada and doctor by profession was suffering from Parkinson's disease, a central nervous system disorder that adversely affected his movements. Dr Venkateshwarlu was bedridden for almost 6 months, after the use of APOSAN pump, the doctor is now back to his normal routine.

The APOSAN  pump is an infusion pump specially designed for continuous subcutaneous infusion of Apomorphine in managing the symptoms of Parkinson’s disease. The pump delivers medication throughout the day to treat motor fluctuations in patients with Parkinson's disease, which are not sufficiently controlled by oral anti-Parkinson medication. The APOSAN   infusion pump provides Apomorphine HCL (5mg/ml).

Says Dr Naveen Thota, MD (General Medicine) DM, Neurology, Consultant Neurologist, ANU Institute of Neuro and Cardiac, “As Parkinson’s disease progresses, the Dopamine storage in the brain becomes increasingly compromised narrowing the therapeutic window for therapy and leading to motor fluctuations. The APOSAN pump is a continuous, subcutaneous infusion of Apomorphine that bypasses the dysfunctional Gastrointestinal (GI) tract to distribute a continuous, accurate the concentration of Dopamine receptor stimulation, for continuous and reliable medication. Dr. Venkateswarlu was suffering from advanced-stage Parkinson’s where  treatment becomes a big challenge. We are happy to note that APOSAN  worked really well on him which has tremendously improved his quality of life.”

Rusan Pharma Ltd. is the first Indian company to indigenously develop, manufacture and market the drug Apomorphine in India to manage the symptoms associated with Parkinson’s disease. They are also the only Indian company to receive approval from the Drug Controller General of India (DCGI).

APOSAN is used for the treatment of motor fluctuations in patients with Parkinson’s Disease which are not sufficiently controlled by oral anti-Parkinson’s medication currently available in India. APOSAN   is today available in the form of injections, pen, and continuous infusion pumps.

Share